Medication guide
Mounjaro
tirzepatide
A plain-language guide to approved uses, available forms, dosing, safety, and the practical questions to discuss before treatment.
What is Mounjaro?
Mounjaro is a prescription gip/glp-1 receptor agonist that contains tirzepatide. It is used for the specific populations and purposes listed in its FDA prescribing information. A shared ingredient or drug class does not make different brands interchangeable.
How it works
tirzepatide acts on incretin signaling involved in glucose regulation, appetite, and digestion. The clinical reason for using it, expected monitoring, and appropriate dose depend on the exact product and the person receiving it.
Indications
- Adults and pediatric patients age 10 years and older: Glycemic control for type 2 diabetes alongside diet and exercise.
Formulations and dosing
Injection
Subcutaneous · Once weekly
Adult dosing
Starting: 2.5 mg once weekly for 4 weeks
Maintenance: 5 mg to 15 mg once weekly
Maximum: 15 mg once weekly
Pediatric dosing
Starting: 2.5 mg once weekly for 4 weeks
Maintenance: 5 mg to 10 mg once weekly
Maximum: 10 mg once weekly
Warnings
- The prescribing information carries a boxed warning about thyroid C-cell tumors observed in rodents; whether this risk applies to humans is unknown.
- Acute pancreatitis has been reported. Persistent severe abdominal pain requires prompt medical evaluation.
- Nausea, vomiting, or diarrhea can lead to dehydration and acute kidney injury.
- Severe gastrointestinal adverse reactions and acute gallbladder disease are described in the prescribing information.
- Serious hypersensitivity reactions can occur.
- The risk of hypoglycemia can increase when used with insulin or an insulin secretagogue.
- Delayed gastric emptying may affect oral medicines and is relevant before procedures using anesthesia or deep sedation.
Contraindications
- A personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
- A serious hypersensitivity reaction to the active ingredient or any product excipient.
What effectiveness evidence can tell you
FDA approval is based on studies of the product for defined uses and populations. Study averages cannot predict an individual response, and results should be interpreted alongside dose reached, treatment duration, side effects, other care, and the study population. The prescribing information below is the starting source for the product’s approved evidence and safety profile.
Cost and coverage
Insurance coverage may depend on the diagnosis, plan formulary, prior-authorization rules, and the exact brand. Before committing to care, confirm the medication cost, clinical or subscription fees, laboratory costs, refill process, and what happens if coverage changes. Prices and coverage should be checked directly rather than assumed from an advertised starting price.
Lifestyle considerations
Medication does not automatically preserve muscle, improve fitness, or meet nutrition needs. A practical plan can include manageable meals, adequate fluid, progressive strength work, aerobic activity, sleep, and follow-up adapted to symptoms and health history. Reduced appetite is not a reason to ignore persistent difficulty eating or drinking.
Questions to ask your clinician
- Which approved use and treatment goal apply to me?
- How will the dose be increased, and what would delay an increase?
- Which symptoms need a routine call, urgent advice, or emergency care?
- Could this affect my other medicines or an upcoming procedure?
- How will we evaluate benefit, tolerability, and ongoing access?